Detection of RSV using nasopharyngeal swabs alone underestimates RSV-related hospitalization incidence in adults: the Multispecimen study’s Final Analysis
Elizabeth Begier(Pfizer (United States)), Bradford D Gessner(Pfizer (United States)), Sonal Uppal(Pfizer (United States)), Thomas Chandler(Norton Healthcare), Paula Peyrani(University of Louisville), Alan D. Junkins(Norton Healthcare), Caroline Kassee(Sinai Health System), Negar Aliabadi(Pfizer (United States)), Kevin Katz(Sunnybrook Hospital), Samira Mubareka(Sunnybrook Health Science Centre), Julio A. Ramírez(Norton Healthcare), Malak Elsobky(Pfizer (United States)), Kari Yacisin(Pfizer (United States)), Allison McGeer(Sinai Hospital), Luis Jódar(Pfizer (United States)), Ruth Carrico(University of Louisville), Edward E. Walsh(University of Rochester), Stephen Furmanek(Norton Healthcare), Christie Vermeiren, Ann R. Falsey(University of Rochester), Zoë Zhong(Sinai Health System), Qing Liu(Dalian Medical University), Elisa Gonzalez(Pfizer (United States)), Robin Hubler(Pfizer (United States)), Warren V. Kalina(Pfizer (United States)), Ashley M Wilde(Norton Healthcare)
Cited by 5
Related Papers
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
|New England Journal of Medicine|2020|15.7k
Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates
|New England Journal of Medicine|2020|2.7k
Respiratory Syncytial Virus Infection in Elderly and High-Risk Adults
|New England Journal of Medicine|2005|2.2k